Cardiovascular Complications in newly diagnosed rheumatic heart disease patients at Mulago Hospital, Uganda

Cardiovascular Journal of Africa

Volumn 24, Issue 3, 2013, Pages 80-85

  Okello, Emmy ^a   Wanzhu, Zhang ^a   Musoke, Charles ^a   Twalib, Aliku ^a   Kakande, Barbara ^a   Lwabi, Peter ^a   Wilson, Nyakoojo B ^a   Mondo, Charles K ^a   Odoi Adome, R ^a   Freers, Juergen ^a  

^a MAKERERE UNIVERSITY   (Uganda)

Author keywords

Complications; Newly diagnosed patients; Rheumatic heart disease

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; BACTERIAL ENDOCARDITIS; CARDIOVASCULAR DISEASE; CEREBROVASCULAR ACCIDENT; FEMALE; FOLLOW UP; HEART ATRIUM FIBRILLATION; HEART FAILURE; HUMAN; MAJOR CLINICAL STUDY; MALE; PULMONARY HYPERTENSION; RECURRENT DISEASE; RHEUMATIC FEVER; RHEUMATIC HEART DISEASE; UGANDA;

ADOLESCENT; ADULT; ATRIAL FIBRILLATION; CHI-SQUARE DISTRIBUTION; CROSS-SECTIONAL STUDIES; FEMALE; HEART FAILURE; HOSPITALS, UNIVERSITY; HUMANS; HYPERTENSION, PULMONARY; MALE; MIDDLE AGED; PROGNOSIS; RECURRENCE; REFERRAL AND CONSULTATION; RHEUMATIC FEVER; RHEUMATIC HEART DISEASE; STROKE; UGANDA; YOUNG ADULT;

EID: 84878264635     PISSN: 19951892     EISSN: None     Source Type: Journal    
DOI: 10.5830/CVJA-2013-004     Document Type: Article

References (42)

1. Carapetis JR, Steer AC, Mulholland EK, Weber M. The global burden of group A streptococcal diseases. Lancet Infect Dis 2005;5:685-694.
2. Longo-Mbenza B, Bayekula M, Ngiyulu R, Kintoki VE, Bikangi NF, et al. Survey of rheumatic heart disease in school children of Kinshasa town. Int J Cardiol 1998;63:287-294.
3. Ibrahim-Khalil S, Elhag M, Ali E, et al. An epidemiological survey of rheumatic fever and rheumatic heart disease in Sahafa town, Sudan. J Epidemiol Commun Health 1992;5:477-479.
4. Jovanoviæ DR, Beslaæ-Bumbasireviæ L, Raiceviæ R, et al. Etiology of ischemic stroke among young adults of Serbia (Abstract). Vojnosanit Pregl 2008;65:803-809.
5. Sliwa K, Carrington M, Bongani MM, Zigiriadis E, Mvungi R, et al. Incidence and characteristics of newly diagnosed rheumatic heart disease in Urban African adults: insights from the Heart of Soweto Study. Eur Heart J 2010;31:719-727.
6. Sani M, Karaye KM, Borodo MM. Prevalence and pattern of rheumatic heart disease in the Nigerian savannah: an echocardiographic study. Cardiovasc J Afr 2007;18:295-299.
7. Kakkar N, Kaur R. Knowledge base of clinicians regarding oral anticoagulant therapy in a teaching institution - a questionnaire survey. J Assoc Physicians India 2004;52:868-872.
8. Manyemba J, Mayosi BM. Penicillin for secondary prevention of rheumatic fever. Cochrane Database Syst Rev 2002;3:CD002227.
9. Mayosi BM. A proposal for the eradication of rheumatic fever in our lifetime. S Afr Med J 2006;96:229-230.
10. Mayosi BM, Robertson K, Volmink, et al. The Drakensberg declaration on the control of rheumatic fever and rheumatic heart disease in Africa. S Afr Med J 2006;96:246.
11. Sahn DJ, DeMaria A, Kisslo J, Weyman A. The committee on M-mode standardization of the American Society of Echocardiography. Recommendations regarding quantification in M-mode echocardiography: results of a survey of echocardiographic measurements. Circulation 1978;58:1072-1083.
12. Carapetis J, Paar J, Cherian T. Standardization of epidemiologic protocols for surveillance of post-streptococcal sequelae: acute rheumatic fever, rheumatic heart disease and acute post-streptococcal glomerulonephritis. National Institutes of Allergy and Infectious Disease, 2006. http://www.niaid.nih.gov/topics/strepThroat/Documents/groupasequelae.pdf.
13. McKee PA, Castelli WE, McNamara PM, Kannel WB. The natural history of congestive heart failure: the Framingham study. New Engl J Med 1971;285:1441-1446.
14. Special writing group of the committee on rheumatic fever. Guidelines for the diagnosis of acute rheumatic fever: Jones criteria. J Am Med Assoc 1992;268:2068-2073.
15. Rheumatic fever and rheumatic heart disease: report of a WHO expert consultation, Geneva, 29 October - 1 November 2001. Geneva: World Health Organization, 2004.
16. Mylonakis E, Calderwood SB. Infective endocarditis in adults. N Engl J Med 2001;345:1318-1330.
17. Prineas RJ, Rischard SC, Blackburn H. The Minnesota Code Manual of Eelectrocardiographic Findings: Standards and Procedures for Measurement and Classification. Boston, MA: John Wright, 1982.
18. Barst RJ, McGoon M, Torbicki A, et al. Diagnosis and differential assessment of pulmonary arterial hypertension. J Am Coll Cardiol 2004;43(Suppl):40S-47S.
19. Muna WFT. Cardiovascular disorders in Africa. World Health Stat Q 1993;46:125-126.
20. Ravisha MS, Tullu MS, Kamat JR. Rheumatic fever and rheumatic heart disease: clinical profile of 550 cases in India. Arch Med Res 2003;34:382-387.
21. Kayima J, Mungoma M, Mondo C, Freers J. The changing pattern of cardiac disease in Africa: the Ugandan experience. Cardiovasc J Afr 2011;22:S9.
22. Kumar R. Controlling rheumatic heart disease in developing countries. World Health Forum 1995;16:47-51.
23. Jaine R, Baker M, Venugopal K. Acute rheumatic fever associated with household crowding in a developed country. Pediatr Infect Dis J 2011;30:315-319.
24. Vahanian M, Baumgartner H, Bax J, et al. Guidelines on the management of valvular heart disease: The Task Force on the Management of Valvular Heart Disease of the European Society of Cardiology. Eur Heart J 2007;28:230.
25. Tornos P, Sambola A, Permanyer-Miralda G, et al. Long-term outcome of surgically treated aortic regurgitation: Influence of guideline adherence toward early surgery. J Am Coll Cardiol 2006;47:1012.
26. Bonow RO, Carabello BA, Chatterjee K, de Leon AC Jr, Faxon DP, et al. Focused update incorporated into the ACC/AHA 2006 guidelines for the management of patients with valvular heart disease: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 1998 Guidelines for the Management of Patients with Valvular Heart Disease): Endorsed by the Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons. Circulation 2008;118:e523-661.
27. Harikrishnan S, Kartha CC. Pulmonary hypertension in rheumatic heart disease. Pulmon Vasc Res Inst Rev 2009;1:13-19.
28. Bahl V, Chandra S, Talwar K, Kaul U, Sharma S, et al. Balloon mitral valvotomy in patients with systemic and suprasystemic pulmonary artery pressures. Catheter Cardiovasc Diagn 1995;36:211-215.
29. Jones T. Diagnosis of rheumatic fever. J Am Med Assoc 1944;126:481-484.
30. Essop MR, Wisenbaugh T, Sareli P. Evidence against a myocardial factor as a cause of ventricular dilatation in active rheumatic carditis. J Am Coll Cardiol 1993;22:826-829.
31. Kassem AS, Zaher SR, Abou Shleib H, el-Kholy AG, Madkour AA, et al. Rheumatic fever prophylaxis using benzathine penicillin G (BPG): two week versus four-week regimens: comparison of two brands of BPG. Pediatrics 1996;97:992-995.
32. Lue HC, Wu MH, Wang JK, Wu FF, Wu YN. Three-versus four-week administration of benzathine penicillin G: effects on incidence of streptococcal infections and recurrences of rheumatic fever. Pediatrics 1996;97:984-988.
33. Wolf P, Abbott R, Kannel W. Atrial fibrillation as an independent risk factor for stroke: The Framingham Study. Stroke 1991;22:983-988.
34. Schopka S, Christof S, Andreas K, Kortner A, Tafelmeier A, et al. Ablation of atrial fibrillation with the Epicor system: a prospective observational trial to evaluate safety and efficacy and predictors of success. J Cardiothorac Surg 2010;5:34.
35. Jørgensen HS, Nakayama H, Reith J, Raaschou HO, Olsen TS. Acute stroke with atrial fibrillation. The Copenhagen Stroke study. Stroke 1996;27:1765-1769.
36. Feinberg WM, Blackshear JL, Laupacis A, Kronmal R, Hart RG. Prevalence, age distribution, and gender of patients with atrial fibrillation. Analysis and implications. Arch Intern Med 1995;155:469-473.
37. Kakkar N, Kaur R. Knowledge base of clinicians regarding oral anticoagulant therapy in a teaching institution - a questionnaire survey. J Assoc Physicians India 2004;52:868-872.
38. You JH, Chan FW, Wong RS, Cheng G. Is INR between 2.0 and 3.0 the optimal level for Chinese patients on warfarin therapy for moderateintensity anticoagulation? Br J Clin Pharmacol 2005;59:582-587.
39. Roy D, Marchand E, Gagné P, Chabot M, Cartier R. Usefulness of anticoagulant therapy in the prevention of embolic complications of atrial fibrillation. Am Heart J 1986;112:1039-1043.
40. Kakkar N, Kaur R, John M. Outpatient oral anticoagulant management - an audit of 82 patients. J Assoc Physicians India 2005;53:847-852.
41. Wyse DG, Waldo AL, Di Marco JP, et al. Atrial Fibrillation Followup Investigation of Rhythm Management (AFFIRM) investigators. A comparison of rate control and rhythm control in patients with atrial fibrillation. N Engl J Med 2002;347:1825-1833.
42. Reményi B, Wilson N, Steer A, Ferreria B, Kado J, Kumar K, et al. World Heart Federation criteria for echocardiographic diagnosis of rheumatic heart disease - an evidence-based guideline. Nat Rev Cardiol 2012;5:297-309.